DENTSPLY SIRONA Inc (XRAY) Receives Consensus Rating of “Hold” from Analysts
DENTSPLY SIRONA Inc (NASDAQ:XRAY) has been assigned an average rating of “Hold” from the sixteen analysts that are presently covering the company, MarketBeat Ratings reports. Three investment analysts have rated the stock with a sell rating, four have issued a hold rating and eight have assigned a buy rating to the company. The average twelve-month target price among brokers that have updated their coverage on the stock in the last year is $68.92.
A number of analysts have recently issued reports on XRAY shares. Zacks Investment Research lowered DENTSPLY SIRONA from a “hold” rating to a “sell” rating in a research report on Monday, October 30th. BidaskClub lowered DENTSPLY SIRONA from a “strong-buy” rating to a “buy” rating in a research report on Saturday, December 2nd. Robert W. Baird set a $63.00 target price on DENTSPLY SIRONA and gave the stock a “buy” rating in a research report on Thursday, October 19th. Credit Suisse Group lowered DENTSPLY SIRONA to a “hold” rating and set a $73.00 target price on the stock. in a research report on Friday, January 5th. Finally, Stephens started coverage on DENTSPLY SIRONA in a research report on Tuesday, November 28th. They set an “overweight” rating and a $75.00 target price on the stock.
In other news, CFO Nicholas W. Alexos acquired 50,000 shares of the stock in a transaction that occurred on Monday, November 13th. The stock was purchased at an average cost of $65.85 per share, with a total value of $3,292,500.00. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Eric Brandt sold 6,409 shares of the business’s stock in a transaction dated Monday, January 8th. The shares were sold at an average price of $68.04, for a total value of $436,068.36. Following the completion of the sale, the director now directly owns 12,073 shares of the company’s stock, valued at $821,446.92. The disclosure for this sale can be found here. 1.99% of the stock is owned by insiders.
Shares of DENTSPLY SIRONA (XRAY) traded up $0.33 during midday trading on Friday, hitting $57.18. The stock had a trading volume of 3,479,229 shares, compared to its average volume of 2,609,912. DENTSPLY SIRONA has a twelve month low of $52.53 and a twelve month high of $68.98. The stock has a market capitalization of $13,390.51, a price-to-earnings ratio of -16.48, a price-to-earnings-growth ratio of 2.15 and a beta of 1.18. The company has a debt-to-equity ratio of 0.21, a quick ratio of 1.59 and a current ratio of 2.32.
The company also recently disclosed a quarterly dividend, which was paid on Friday, January 12th. Investors of record on Friday, December 29th were issued a $0.0875 dividend. This represents a $0.35 annualized dividend and a yield of 0.61%. The ex-dividend date was Thursday, December 28th. DENTSPLY SIRONA’s dividend payout ratio is currently -10.09%.
ILLEGAL ACTIVITY NOTICE: “DENTSPLY SIRONA Inc (XRAY) Receives Consensus Rating of “Hold” from Analysts” was published by Daily Political and is the sole property of of Daily Political. If you are accessing this piece of content on another domain, it was illegally stolen and reposted in violation of U.S. and international copyright laws. The original version of this piece of content can be viewed at https://www.dailypolitical.com/2018/02/09/dentsply-sirona-inc-xray-receives-consensus-rating-of-hold-from-analysts.html.
DENTSPLY SIRONA Company Profile
DENTSPLY SIRONA Inc is a manufacturer of professional dental products and technologies. The Company develops, manufactures, and markets solutions offering, including dental and oral health products, as well as other consumable medical devices. It operates through two segments: Dental and Healthcare Consumables, and Technologies.
Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.